Biotheranostics CancerTYPE ID aids in patient selection for immunotherapy
21 sept. 2020 08h00 HE
|
Biotheranostics, Inc.
San Diego, CA, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Biotheranostics announces the publication of a new study evaluating CancerTYPE ID® and its role in identifying subsets of patients with Cancer of...
New approach to assessing rejection in heart transplant patients far more effective
05 avr. 2019 12h24 HE
|
International Society for Heart & Lung Transplantation
ORLANDO, Fla., April 05, 2019 (GLOBE NEWSWIRE) -- A new method of assessing organ rejection in heart transplant patients is more effective at estimating the probability of rejection than current...